HEOR Study Manager to Q-linea

Q-linea continues to grow and is now looking to recruit a Health economics and outcomes research (HEOR) Study Manager to join the company. Q-linea develops and delivers innovative solutions for the diagnosis of infectious diseases, with a keen focus on improving sepsis treatment while reducing antibiotic resistance. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing (AST), which produces a sensitivity profile from a positive blood culture in approximately six hours. This is 24 to 40 hours faster than current diagnostics.
As a HEOR Study Manager, you will have a key role in contributing to the uptake of new products and help bring about a new reality of faster phenotypic AST that allows healthcare providers to accurately diagnose and treat infectious diseases in the shortest possible time. In this role, you will have the opportunity to manage and contribute to multiple projects and collaborate cross-functionally with internal and external stakeholders. We are looking for a HEOR study manager who likes to team up with multiple internal and external stakeholders and wants an exciting position at a company in the forefront of innovative infectious disease diagnostics.

Q-linea has its HQ in Uppsala Sweden and is listed on the Nasdaq Stockholm Mid Cap. The position is full-time and preferably based in Stockholm or Uppsala, Sweden. We welcome your application today!


Responsibilities
As a HEOR Study Manager, you will be part of the team inside the Clinical Value Department at Q-linea and report directly to Chief Medical Officer (CMO) at the company.

Duties and responsibilities include:
• Prepare protocols of studies aiming to prove clinical, organizational and economic benefits of using Q-linea products, in collaboration with Health Economics experts.
• Compile study related documentation, including Ethical board applications, informed consent forms, safety documentation, and clinical record forms for interventional studies.
• Conduct narrative and systematic literature reviews in support of study rationale.
• Manage relationships with study sites, Q-linea teams (e.g., Operations, Customer Care, RA/QA) and external stakeholders (e.g., health economists, statisticians, CRO) to plan and execute studies.
• Ensure communication of relevant study information across study personnel, timely communication of urgent information to the appropriate Team members, and appropriate escalation of issues to study team leadership.
• Stay updated on the relevant procedures linked to the role


Your profile
The suitable candidate has the following qualifications:

Education:
- BSc or higher (MSc, PhD) degree within Life Sciences
Experience:
- At least 3-year experience in clinical trial management within a CRO working for in vitro diagnostic companies or experience within the in-vitro diagnostic industry and/or academia
- Knowledge of Clinical Microbiology or familiarity with rapid in-vitro diagnostics acquired within the in-vitro diagnostic industry or academia
Language:
- English fluency, both written and oral
Competencies:
- Proficiency with the use of research literature databases (e.g., Medline, Pubmed, Embase)
- Knowledge of IVDR and ISO 20916 requirements, as well as Health economic evaluation reporting standards (CHEERS) is a strong plus

The ideal candidate for this position is result-driven, well organized and has excellent time-management and communication skills. Strong problem-solving skills and ability to work on multiple and complex projects at the same time are required to be successful in this role. Furthermore, we believe that you have an eye for detail and ability to work in a team and to adjust to changing priorities.
If you are ready to bring your skills and dedication to this position, we are ready to offer you an exciting and dynamic work environment where you will make a key difference and help patients get better clinical outcomes!


About the organisation
Q-linea AB is a public-listed diagnostic company focused on developing and delivering solutions to enable healthcare providers to diagnose and treat infectious diseases in the shortest possible time. Our vision is to help save lives by, as an innovative pioneer, ensuring that antibiotics can be maintained as an effective treatment for future generations. The company was founded in 2008 around technology developed by researchers from the Rudbeck Laboratory at Uppsala University, together with Olink Bioscience AB and Uppsala University's holding company UUAB. Q-linea today consists of a 100+ interdisciplinary and highly motivated team that conducts its operations in modern and well adapted premises in Uppsala Science Park and in Fyrislund. You can find more information about Q-Linea at www.qlinea.com